$57.08 0.28 (+0.49%)
11/25/2009 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Featured Broker Partners